Tags : Merge

Exact Sciences to Merge with Genomic Health Forming a New

Shots: Exact Sciences enter into a merger agreement with Genomic in cash & stock transaction for $72/share making the total deal value $2.8B. Genomic to receive $27.50 in cash & $44.50 in shares of Exact Sciences stock for each owned share based on the closing price value as of Jul 26, 2019. The transaction is […]Read More

Pfizer in Talks with Mylan to Merge its Off-Patent Drug

Shots: Pfizer plans to combine its off-patent drug business with Mylan with the formation of a new entity for the generic business. Post completion of the deal, Mylan will hold 40% of the shares and remaining will belong to Pfizer The merger will boost the sales of therapies which slowed due to loss of patent […]Read More